tiprankstipranks
Trending News
More News >
Innovent Biologics (IVBXF)
OTHER OTC:IVBXF
US Market

Innovent Biologics (IVBXF) Balance Sheet

Compare
33 Followers

Innovent Biologics Balance Sheet

Innovent Biologics's total assets for Q4 2024 were ¥21.60B, an increase of 6.44% from the previous quarter. IVBXF total liabilities were ¥8.48B for the fiscal quarter, a 7.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
¥ 21.60B¥ 20.63B¥ 17.59B¥ 16.24B¥ 11.83B
Total Liabilities
¥ 8.48B¥ 8.10B¥ 6.86B¥ 5.91B¥ 3.06B
Total Equity Gross Minority
¥ 13.12B¥ 12.53B¥ 10.73B¥ 10.33B¥ 8.78B
Other Metrics
Currency in CNY

Innovent Biologics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis